Medicare Expands Program Paying for Chronic Care Tech

Millions of Americans with chronic health conditions just got a major boost in how their care might be delivered and paid for.

Medicare announced this week it's expanding ACCESS, a pilot program that flips the traditional healthcare payment model on its head. Instead of paying providers just for services, the program pays them more when patients actually get better.

The program launched last year covering five conditions: diabetes, high blood pressure, chronic pain, depression, and anxiety. Now Medicare is adding five more: substance use disorder, heart failure, chronic obstructive pulmonary disease, tobacco use, and extended musculoskeletal care support.

The expansion means about 75% of Medicare beneficiaries will qualify for at least one track of the program. That's tens of millions of people who could benefit from technology-supported care that's directly tied to their health outcomes.

Here's what makes ACCESS different. Approved healthcare technology companies get paid based on results. If a patient's diabetes improves, blood pressure drops, or depression lifts, providers earn more. If outcomes don't improve, payments reflect that reality.

The new condition tracks will launch in spring 2027, giving approved companies time to develop programs and patients time to learn about their options. The timing matters particularly for conditions like substance use disorder and heart failure, which require ongoing support and monitoring that technology can provide between doctor visits.

The Ripple Effect

This expansion signals a fundamental shift in how America thinks about paying for healthcare. For decades, the system rewarded volume over value, procedures over progress, and interventions over improvements.

ACCESS represents something different: accountability. When providers succeed only if patients improve, everyone's incentives align. Companies invest in tools that actually work. Patients get support that continues beyond a 15-minute appointment. And Medicare spends money on what delivers results.

The model could reshape how private insurers think about chronic disease management too. If Medicare proves that outcome-based payments work for conditions affecting millions of Americans, other insurers will likely follow. That means better care models spreading beyond just Medicare beneficiaries.

The expansion also acknowledges that chronic conditions don't exist in isolation. Someone with diabetes might also struggle with depression. A person with chronic pain might use tobacco. By covering more conditions, ACCESS can support the whole person, not just individual diagnoses.

Technology plays a starring role here, from apps that remind patients to take medications to wearables that track vital signs to telehealth platforms connecting people with specialists. These tools work best when providers have real incentives to make them effective, not just to prescribe them.

Medicare's willingness to expand ACCESS before the original pilot even reaches its first anniversary shows confidence in the model's potential. When a program affecting healthcare for millions gets bigger this quickly, it signals that early results look promising.